Endexx

Endexx CROIC

The Cash Return on Invested Capital (CROIC) of Endexx (EDXC) as of Oct 21, 2026 is -361.55 %. In the previous year, Cash Return on Invested Capital (CROIC) was 120.59 % — a change of -399.83% (lower).

CROIC

-361.55 %

YoY

-399.83%

Last updated:

Cash Return on Invested Capital (CROIC) of Endexx is 2022 -361.55 % . Cash Return on Invested Capital (CROIC) of Endexx was 2021 120.59 % . It decreases by -399.83% lower compared to the previous year.

The Endexx CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
80.96 USD
Jan 1, 2019
98.07 USD
Jan 1, 2020
38.46 USD
Jan 1, 2021
120.59 USD
Jan 1, 2022
-361.55 USD
The Endexx CROIC history
YEARCROICYoY
-361.55 %-399.83%
120.59 %+213.54%
38.46 %-60.78%
98.07 %+21.13%
80.96 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Endexx Stock analysis

What does Endexx do? Endexx Corp. develops hemp-derived cannabidiol-based products through its subsidiaries, selling oils, extracts, topicals, and pet products via its e-commerce site cbdunlimited.com and other online and in-store retailers. The Gorilla-Tek division provides an automated dispensing system for secure distribution of hemp-based products. Seed-to-Shelf offers compliance and inventory tracking technology for regulated hemp product management. The company targets consumers seeking therapeutic relief for pain and inflammation, as well as retailers and pharmacies needing regulatory support systems. Endexx Corp. generates revenue from direct sales of CBD products through its website and retail partners, automated dispensing systems sold to businesses, and technology solutions like Seed-to-Shelf for industry compliance. Its consumer products are marketed to individuals and pet owners, while its technology services are sold to hemp industry businesses requiring regulatory and operational support. The company's subsidiaries handle product development, retail distribution, and technology services for the hemp sector. The firm's primary revenue streams include e-commerce sales of CBD oils, extracts, topicals, and pet products, automated dispensing systems for secure product distribution, and technology platforms such as Seed-to-Shelf for compliance and inventory management. These offerings cater to both end consumers and business clients in the hemp industry, with the Gorilla-Tek division focusing on dispensing solutions and Seed-to-Shelf supporting pharmacy and retail operations through process management systems. Endexx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Endexx stock

Cash Return on Invested Capital (CROIC) of Endexx is -361.55 % in 2022.

Cash Return on Invested Capital (CROIC) of Endexx changed from 120.59 % to -361.55 %, representing a -399.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Endexx since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Endexx with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Endexx

All Key Metrics — Endexx